Wei Long Ng
May Win Naing
Ratima Suntornnond
Sanjairaj Vijayavenkataraman- 1HP-NTU Digital Manufacturing Corporate Lab, Nanyang Technological University (NTU), Singapore, Singapore
- 2Singapore Institute of Manufacturing Technology (SIMTech), Agency for Science, Technology and Research (A*STAR), Singapore, Singapore
- 3Biomanufacturing Technology, Bioprocessing Technology Institute (BTI), Agency for Science, Technology, and Research (A*STAR), Singapore, Singapore
- 4The Vijay Lab, Division of Engineering, New York University Abu Dhabi, Abu Dhabi, United Arab Emirates
- 5Department of Mechanical and Aerospace Engineering, Tandon School of Engineering, New York University, Brooklyn, NY, United States
Editorial on the Research Topic
Fabrication of in - vitro 3D human tissue models - from cell processing to advanced manufacturing
Over the years, the field of toxicology testing has pivoted from the use of animal models to 2D human cell cultures and finally the adaptation of in-vitro 3D human testing models. It is important that these in-vitro 3D human testing models predicts the human responses in an accurate and reliable manner (Nam et al., 2015; Ng and Yeong, 2019). This is largely driven by the significant discrepancies between adverse effects of chemicals in humans and animals (Lilienblum et al., 2008). The use of animal models has several caveats which include the differences in the absorption or distribution of the chemicals/substances; the way the substances are metabolized and the short duration of animal lifespan to accurately monitor disease development. Similarly, conventional 2D cell culture is unable to adequately recapitulate the in vivo cell-cell and cell-matrix interactions found in native three-dimensional (3D) tissues and it has been reported that numerous types of cells have expressed different phenotypes and genomic profiles in 2D versus 3D cell culture (Duval et al., 2017; Jensen and Teng, 2020).
Hence, in-vitro 3D human tissue models would bring about the necessary complexity that may improve the reliability and accuracy of test outcomes. Some of the fabricated in-vitro 3D human tissue models for various testing applications include skin tissue models (Ng et al., 2018; Liu et al., 2020; Zhang et al., 2021), alveolar lung tissue models (Klein et al., 2013; Costa et al., 2019; Ng et al., 2021) and liver tissue models (Lee et al., 2015; Skardal et al., 2015; Hiller et al., 2018). However, there are some challenges faced in translating this to widespread use. Successful production of in-vitro tissue models is dependent on two critical aspects–ability to carry out large-scale manufacturing of cells (growing cells in vast quantities within a homogeneous physical and chemical environment) (Jordan et al., 2018; He et al., 2019; Chen et al., 2022) and advanced manufacturing platforms (highly-automated fabrication of in-vitro tissue models with high throughput rates and repeatability) (Ozbolat and Hospodiuk, 2016; Ng et al., 2019; Zhuang et al., 2019; Ng et al., 2020a; Ng et al., 2020b; Li et al., 2020; Ng et al., 2022; Suntornnond et al., 2022).
The goal of this Research Topic is to focus on the recent developments in cell processing techniques and advanced manufacturing approaches which include the current state-of-the-arts, recent developments and major accomplishments, future challenges, and directions towards fabrication of 3D in-vitro human tissue models, specifically in large-scale cell manufacturing and advanced manufacturing platforms.
There is a total of 6 published articles in this Research Topic: 2 review papers and 4 original research papers. One of the review papers is on large-scale cell manufacturing and it introduced a new multiple-use aseptic connector that can act as potential replacement for two main types of commonly-used devices for small volume fluid transfers (single-use sterile connectors and tube welders) in cell therapy manufacturing. The review paper highlighted that multiple-use aseptic connector can fulfil the unmet need for a sterile connector suitable for small volume fluid transfers and reduce the footprint, complexity and cost of culture systems (Wu et al.). The next review paper is on advanced manufacturing platforms and it discussed how the emergence and development of smart metamaterial, advanced optimization algorithm and advanced manufacturing technique have resulted in a paradigm shift in the design, fabrication and characterization of bone scaffolds (Huo et al.). The review paper provided detailed information on the design of microstructure of the bone scaffold, application of metamaterial in the design of bone scaffolds and optimization of the microstructure in bone scaffolds, the advanced manufacturing of bone scaffolds and lastly the various techniques used for evaluating the performance of bone scaffolds.
Next, the 4 original research papers are related to the advanced manufacturing platforms. One of the original research papers reported a versatile cell-friendly photopolymerization approach that facilitated single-step fabrication of hollow-core and solid-core hydrogel fibres loaded with living cells (Savelyev et al.). The approach was implemented by extruding cell-laden hyaluronic acid glycidyl methacrylate hydrogel directly into an aqueous solution containing free radicals generated by continuous blue light photo-excitation of the flavin mononucleotide/triethanolamine photo-initiator to induce diffusion-limited photo-fabrication. The next original research paper reported the fabrication of affordable, flexible and highly-reproducible 3D bioprinted colorectal cancer model (Sbirkov et al.). The fabricated 3D colorectal cancer models exhibited greater pathomorphological resemblance to tumours and increased overall resistance to commonly used chemotherapeutics as compared to 2D cell cultures. Hence, the study has reported a novel accessible 3D tissue model platform for disease modelling and drug testing. Another original research paper demonstrated the potential of micro-vascularized skin-on-a-chip tissue equivalents for systematic delivery of therapeutics (Jones et al.). The novel vascularized skin-on-a-chip model consisted of human-derived primary and immortalized cells (pericyte co-cultures); the results indicated that vascularization enhanced the stratification and differentiation of the epidermis to form matured skin equivalents in microfluidic chips. The last original research paper demonstrated the fabrication of personalized 3D-printed bioresorbable airway external splint for sever tracheomalacia (Yu et al.). The study evaluated the performance of 3D-printed bioresorbable airway external splint on nine different young patients with severe tracheomalacia and the results showed that the 3D printed splint not only limited the external compression and prevented airway collapse but also ensured the growth potential of the airway, making it a safe, reliable, and effective treatment for congenital heart disease patients with tracheomalacia.
Numerous studies have shown that the use of conventional 2D cell culture is unable to adequately recapitulate important in-vivo cell-cell and cell-matrix interactions and numerous cell types have expressed different phenotypes and genomic profiles in 2D versus 3D cell culture (Breslin and O’Driscoll, 2013; Ng et al., 2016; Laschke and Menger, 2017). The combination of advanced cell processing approaches and 3D bioprinting technology is critical for highly-reproducible automated fabrication of 3D human tissue models for various testing applications. We anticipate that insights and perspectives from this Research Topic would encourage the use of biomimetic 3D human tissue models for various drug/chemical testing applications to improve the prediction of human responses in an accurate and reliable manner.
Author contributions
All authors listed have made a substantial, direct, and intellectual contribution to the work and approved it for publication.
Conflict of interest
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Publisher’s note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.
References
Breslin, S., and O’driscoll, L. (2013). Three-dimensional cell culture: The missing link in drug discovery. Drug Discov. today 18, 240–249. doi:10.1016/j.drudis.2012.10.003
Chen, S., Bin Abdul Rahim, A. A., Wang, W.-W., Cheong, R., Prabhu, A. V., Tan, J. Z. Y., et al. (2022). In-situ scalable manufacturing of Epstein–Barr virus-specific T-cells using bioreactor with an expandable culture area (BECA). Sci. Rep. 12, 7045–7113. doi:10.1038/s41598-022-11015-z
Costa, A., De Souza Carvalho-Wodarz, C., Seabra, V., Sarmento, B., and Lehr, C.-M. (2019). Triple co-culture of human alveolar epithelium, endothelium and macrophages for studying the interaction of nanocarriers with the air-blood barrier. Acta biomater. 91, 235–247. doi:10.1016/j.actbio.2019.04.037
Duval, K., Grover, H., Han, L.-H., Mou, Y., Pegoraro, A. F., Fredberg, J., et al. (2017). Modeling physiological events in 2D vs. 3D cell culture. Physiology 32, 266–277. doi:10.1152/physiol.00036.2016
He, C., Ye, P., Wang, H., Liu, X., and Li, F. (2019). A systematic mass-transfer modeling approach for mammalian cell culture bioreactor scale-up. Biochem. Eng. J. 141, 173–181. doi:10.1016/j.bej.2018.09.019
Hiller, T., Berg, J., Elomaa, L., Röhrs, V., Ullah, I., Schaar, K., et al. (2018). Generation of a 3D liver model comprising human extracellular matrix in an alginate/gelatin-based bioink by extrusion bioprinting for infection and transduction studies. Int. J. Mol. Sci. 19, 3129. doi:10.3390/ijms19103129
Jensen, C., and Teng, Y. (2020). Is it time to start transitioning from 2D to 3D cell culture? Front. Mol. Biosci. 7, 33. doi:10.3389/fmolb.2020.00033
Jordan, M., Mac Kinnon, N., Monchois, V., Stettler, M., and Broly, H. (2018). Intensification of large-scale cell culture processes. Curr. Opin. Chem. Eng. 22, 253–257. doi:10.1016/j.coche.2018.11.008
Klein, S. G., Serchi, T., Hoffmann, L., Blömeke, B., and Gutleb, A. C. (2013). An improved 3D tetraculture system mimicking the cellular organisation at the alveolar barrier to study the potential toxic effects of particles on the lung. Part. Fibre Toxicol. 10, 31. doi:10.1186/1743-8977-10-31
Laschke, M. W., and Menger, M. D. (2017). Life is 3D: Boosting spheroid function for tissue engineering. Trends Biotechnol. 35, 133–144. doi:10.1016/j.tibtech.2016.08.004
Lee, K.-H., Lee, J., and Lee, S.-H. (2015). 3D liver models on a microplatform: Well-defined culture, engineering of liver tissue and liver-on-a-chip. Lab. Chip 15, 3822–3837. doi:10.1039/c5lc00611b
Li, X., Liu, B., Pei, B., Chen, J., Zhou, D., Peng, J., et al. (2020). Inkjet bioprinting of biomaterials. Chem. Rev. 120, 10793–10833. doi:10.1021/acs.chemrev.0c00008
Lilienblum, W., Dekant, W., Foth, H., Gebel, T., Hengstler, J., Kahl, R., et al. (2008). Alternative methods to safety studies in experimental animals: Role in the risk assessment of chemicals under the new European chemicals legislation (REACH). Arch. Toxicol. 82, 211–236. doi:10.1007/s00204-008-0279-9
Liu, X., Michael, S., Bharti, K., Ferrer, M., and Song, M. J. (2020). A biofabricated vascularized skin model of atopic dermatitis for preclinical studies. Biofabrication 12, 035002. doi:10.1088/1758-5090/ab76a1
Nam, K.-H., Smith, A. S., Lone, S., Kwon, S., and Kim, D.-H. (2015). Biomimetic 3D tissue models for advanced high-throughput drug screening. SLAS Technol. 20, 201–215. doi:10.1177/2211068214557813
Ng, W. L., Ayi, T. C., Liu, Y.-C., Sing, S. L., Yeong, W. Y., and Tan, B.-H. (2021). Fabrication and characterization of 3D bioprinted triple-layered human alveolar lung models. Int. J. Bioprint. 7, 332. doi:10.18063/ijb.v7i2.332
Ng, W. L., Chan, A., Ong, Y. S., and Chua, C. K. (2020a). Deep learning for fabrication and maturation of 3D bioprinted tissues and organs. Virtual Phys. Prototyp. 15, 340–358. doi:10.1080/17452759.2020.1771741
Ng, W. L., Chua, C. K., and Shen, Y.-F. (2019). Print me an organ! Why we are not there yet. Prog. Polym. Sci. 97, 101145. doi:10.1016/j.progpolymsci.2019.101145
Ng, W. L., Huang, X., Shkolnikov, V., Goh, G. L., Suntornnond, R., and Yeong, W. Y. (2022). Controlling droplet impact velocity and droplet volume: Key factors to achieving high cell viability in sub-nanoliter droplet-based bioprinting. Int. J. Bioprint. 8, 424. doi:10.18063/ijb.v8i1.424
Ng, W. L., Lee, J. M., Zhou, M., Chen, Y.-W., Lee, K.-X. A., Yeong, W. Y., et al. (2020b). Vat polymerization-based bioprinting—Process, materials, applications and regulatory challenges. Biofabrication 12, 022001. doi:10.1088/1758-5090/ab6034
Ng, W. L., Tan, Z. Q., Yeong, W. Y., and Naing, M. W. (2018). Proof-of-concept: 3D bioprinting of pigmented human skin constructs. Biofabrication 10, 025005–025013. doi:10.1088/1758-5090/aa9e1e
Ng, W. L., Wang, S., Yeong, W. Y., and Naing, M. W. (2016). Skin bioprinting: Impending reality or fantasy? Trends Biotechnol. 34, 689–699. doi:10.1016/j.tibtech.2016.04.006
Ng, W. L., and Yeong, W. Y. (2019). The future of skin toxicology testing - three-dimensional bioprinting meets microfluidics.. Int. J. Bioprint. 5, 237. doi:10.18063/ijb.v5i2.1.237
Ozbolat, I. T., and Hospodiuk, M. (2016). Current advances and future perspectives in extrusion-based bioprinting. Biomaterials 76, 321–343. doi:10.1016/j.biomaterials.2015.10.076
Skardal, A., Devarasetty, M., Soker, S., and Hall, A. R. (2015). In situ patterned micro 3D liver constructs for parallel toxicology testing in a fluidic device. Biofabrication 7, 031001. doi:10.1088/1758-5090/7/3/031001
Suntornnond, R., Ng, W. L., Huang, X., Yeow, E. C. H., and Yeong, W. Y. (2022). Improving printability of hydrogel-based bio-inks for thermal inkjet bioprinting applications via saponification and heat treatment processes. J. Mat. Chem. B 10, 5989–6000. doi:10.1039/d2tb00442a
Zhang, Y., Enhejirigala, E., Yao, B., Li, Z., Song, W., Li, J., et al. (2021). Using bioprinting and spheroid culture to create a skin model with sweat glands and hair follicles. Burns Trauma 9, tkab013. doi:10.1093/burnst/tkab013
Keywords: 3D bioprinting, biofabrication, bio-inks, in-vitro 3D tissue models, cell expansion, microcarriers
Citation: Ng WL, Win Naing M, Suntornnond R and Vijayavenkataraman S (2022) Editorial: Fabrication of in-vitro 3D human tissue models—From cell processing to advanced manufacturing. Front. Bioeng. Biotechnol. 10:1035601. doi: 10.3389/fbioe.2022.1035601
Received: 03 September 2022; Accepted: 09 September 2022;
Published: 26 September 2022.
Edited and reviewed by:
Hasan Uludag, University of Alberta, CanadaCopyright © 2022 Ng, Win Naing, Suntornnond and Vijayavenkataraman. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Wei Long Ng, ng.wl@ntu.edu.sg